Business Wire

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON ®-TB Gold Plus assay on LIAISON ® XS

HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Yahoo Finance

QIAGEN (QGEN), DiaSorin to Broaden Access to Latent TB Testing

QIAGEN N.V. QGEN and DiaSorin recently announced the receipt of FDA approval of the LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated LIAISON XS platform. QIAGEN and DiaSorin ...
Nasdaq

QIAGEN Says FDA Approves QuantiFERON-TB Gold Plus Assay On LIAISON XS Platform

(RTTNews) - QIAGEN (QGEN) and DiaSorin said Monday that the U.S. Food and Drug Administration has approved the LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin's automated LIAISON XS ...
Pharmabiz

US FDA approves Qiagen’s QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated Liaison XS platform for TB testing

Qiagen and DiaSorin announced that the US Food and Drug Administration (FDA) has approved the Liaison QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated Liaison XS platform. The approval ...
Nasdaq

QIAGEN, in partnership with DiaSorin, announces the launch of the new LIAISON® LymeDetect® Assay based on QuantiFERON technology in countries accepting CE Mark for early ...

The LIAISON® LymeDetect® assay is a solution for the early diagnosis of Lyme Borreliosis combining detection of IgG and IgM Antibodies and cellular immunity The test is available in countries ...
Yahoo Finance

QIAGEN (QGEN), DiaSorin to Broaden Access to Latent TB Testing

QIAGEN N.V. QGEN and DiaSorin recently announced the receipt of FDA approval of the LIAISON QuantiFERON-TB Gold Plus assay for use on DiaSorin’s automated LIAISON XS platform. QIAGEN and DiaSorin ...
The Globe and Mail

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced that the U.S. Food and Drug Administration (FDA) has approved the LIAISON ® QuantiFERON ®-TB Gold Plus ...
Finanznachrichten

QIAGEN N.V.: QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON-TB Gold Plus assay on LIAISON XS - FinanzNachrichten.de

Additional U.S. approval for LIAISON XS platform builds on FDA approval in 2019 for QuantiFERON assay running on DiaSorin's LIAISON XL analyzer Collaboration now provides full range of automation ...